Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Hemoglobin ; 44(6): 432-437, 2020 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-33059511

RESUMEN

Thalassemia and hemoglobinopathies are the most common cause of high morbidity and mortality in India. Detection of carriers and premarital counseling play an important role in preventing the birth of a thalassemic child. The present study aimed to detect large numbers of asymptomatic carriers in rural areas of West Bengal, India. The present cross-sectional study was conducted over a period of 10 years. Thalassemia awareness programs and detection camps were organized at the community level. After signed written consent was obtained, the collected blood samples were subjected to a complete blood count (CBC) in an automated blood cell counter and then analyzed by high performance liquid chromatography (HPLC); in difficult cases, samples were sent to the reference laboratory for molecular characterization. Out of 287,258 samples collected, 32,921 (11.46%) cases revealed abnormal hemoglobins (Hbs); of these, 31,782 (11.06%) carried heterozygous states (carriers/traits), and the remainder were either homozygous or compound heterozygous for different hemoglobinopathies. Two common variants were revealed in the study, namely ß-thalassemia (ß-thal) (7.23%) and Hb E [ß26(B8)Glu→Lys, HBB: c.79G>A] (2.77%) traits. Among homozygous or compound heterozygous states, Hb E/ß-thal (0.14%) and ß-thal major (ß-TM) (0.12%) were predominant. In rural areas of West Bengal, the most common Hb variants detected were ß-thal and Hb E traits. In view of the high prevalence of hemoglobinopathies in this region, routine premarital screening and genetic counseling should be emphasized and encouraged to prevent the birth of a thalassemic child, and thus curtailing the burden on families and the health economy.


Asunto(s)
Hemoglobinopatías/epidemiología , Población Rural , Talasemia alfa/epidemiología , Talasemia beta/epidemiología , Alelos , Biomarcadores , Cromatografía Líquida de Alta Presión , Estudios Transversales , Índices de Eritrocitos , Genotipo , Hemoglobinopatías/diagnóstico , Hemoglobinopatías/etiología , Humanos , India/epidemiología , Tamizaje Masivo , Vigilancia de la Población , Prevalencia , Globinas alfa/genética , Talasemia alfa/diagnóstico , Talasemia alfa/etiología , Globinas beta/genética , Talasemia beta/diagnóstico , Talasemia beta/etiología
2.
Appl Biochem Biotechnol ; 175(7): 3371-86, 2015 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-25649444

RESUMEN

This study aimed to explore the bactericidal activity of a feather-degraded active peptide against multiple-antibiotic-resistant (MAR) Staphylococcus aureus. An antibacterial peptide (ABP) was isolated from the chicken feathers containing fermented media of Paenibacillus woosongensis TKB2, a keratinolytic soil isolate. It was purified by HPLC, and its mass was found to be 4666.87 Da using matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) spectroscopy. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of this peptide were 22.5 and 90 µg/ml, respectively. SEM study revealed the distorted cell wall of the test strain along with pore formation. The possible reason for bactericidal activity of the peptide is due to generation of reactive oxygen species (ROS), resulting in membrane damage and leakage of intracellular protein. Complete sequence of the peptide was predicted and retrieved from the sequence database of chicken feather keratin after in silico trypsin digestion using ExPASy tools. Further, net charge, hydrophobicity (77.7 %) and molecular modelling of the peptide were evaluated for better understanding of its mode of action. The hydrophobic region (17 to 27) of the peptide may facilitate for initial attachment on the bacterial membrane. The ABP exhibited no adverse effects on RBC membrane and HT-29 human cell line. This cytosafe peptide can be exploited as an effective therapeutic agent to combat Staphylococcal infections.


Asunto(s)
Farmacorresistencia Bacteriana/inmunología , Staphylococcus aureus Resistente a Meticilina/efectos de los fármacos , Péptidos/administración & dosificación , Infecciones Estafilocócicas/inmunología , Animales , Pollos/inmunología , Cromatografía Líquida de Alta Presión , Plumas/química , Plumas/inmunología , Humanos , Staphylococcus aureus Resistente a Meticilina/inmunología , Pruebas de Sensibilidad Microbiana , Péptidos/inmunología , Péptidos/aislamiento & purificación , Infecciones Estafilocócicas/prevención & control
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...